Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Porcine Vaccine Market Growth in 2025?

The market for porcine vaccines has experienced robust growth in the past few years. The market size is anticipated to rise from $1.89 billion in 2024 to $2.06 billion in 2025, showcasing a compound annual growth rate (CAGR) of 8.8%. Factors contributing to the growth in the earlier period include disease outbreaks and control interventions, a worldwide surge in pork consumption, escalation in pig farming, government efforts towards disease prevention, and programs aimed at raising awareness and education.

What Is the Forecast for the Porcine Vaccine Market Size Through 2029?

The market size for porcine vaccines is predicted to experience considerable expansion in the coming years, with projections suggesting it will reach $2.96 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.5%. This increment during the forecast period is the result of several factors including the global spread of pig farming, increased disease threats, strict regulations, and adherence, advancements in vaccine technology, international trade and disease risk reduction efforts. Key trends to watch during this forecast period include regional adaptation of vaccines, incorporation of biotechnology in vaccine production, heightened awareness regarding zoonotic diseases, the use of genomic strategies in vaccine formulation, and increased focus on research and development investments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp

What are the Key Market Players in Porcine Vaccine Market and How They’re Evolving?

Major companies operating in the porcine vaccine market include Sanofi Pasteur Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Arko Laboratories Limited, Merck Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., Ringpu Bio-Pharmacy Co Ltd., IDT Biologika GmbH, Bimeda Holdings PLC, Jinyu Bio-Technology Co Ltd., Biogénesis Bagó, Pharmaq AS, Veterquimica S.A., Kyoto Biken Laboratories Inc., Dopharma Research B.V., Agrovet Market Animal Health Ltd., Innovad SA, PBS Animal Health, Merial Animal Health, Aptimmune Biologics Inc., Syntex SA de CV, Zoovet S.A., Shenzhen Weierkang Xiang Animal Pharm Co Ltd., Wuhan Keqian Biology Co Ltd., Anicon Labor GmbH

What Are the Primary Growth Drivers in the Porcine Vaccine Market?

The growth of the porcine vaccine market is likely to be propelled by the escalating infection rates of swine disease. Swine flu, a respiratory illness that predominantly affects pigs, is usually triggered by the influenza type A virus, which is a frequent cause of influenza outbreaks in pigs. Porcine vaccines are administered to pigs, stimulating their immune systems to recognize and respond to the pathogenic agent by initiating an immunogenic response. These vaccines condition the pigs’ immune systems to battle pathogens and preclude the disease by engendering an anamnestic response when exposed to the same pathogen again. For example, a report from the UK government in September 2024 illustrated that a potential outbreak of African swine fever (ASF) could dramatically impact the UK’s pig industry, valued at £8 billion, along with its annual exports of pork and related products worth £600 million. The potential financial fallout from such an outbreak is anticipated to be anywhere between £10 million and £100 million. Thus, the escalating infection rates of swine disease are propelling the expansion of the porcine vaccine market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9111&type=smp

What Are the Leading Segments in the Global Porcine Vaccine Industry?

The porcine vaccine market covered in this report is segmented –

1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines

2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications

3) By End User: Veterinary Hospitals, Hog or Pig Production Farm

Subsegments:

1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines

2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines

3) By Toxoid Vaccines: Inactivated Toxins

4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines

5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines

6) By DNA Vaccines: Plasmid DNA Vaccines

What Are the Key Market Trends in the Porcine Vaccine Industry?

In the rapidly progressing animal health sector, key players in the porcine vaccine market are forming strategic alliances to boost their research and development power and solidify their market standing. This merger leverages TVG’s prowess in vaccine tech and Pirbright’s proficiency in African swine fever (ASF) studies. The objective of this alliance is to refine the vaccine creation process and conceive innovative methods that can significantly elevate the health of swine. For instance, in May 2024, The Pirbright Institute, a UK research institute, collaborated with The Vaccine Group (TVG), a UK firm, to work on an ASF vaccine. The study focuses on generating vaccines to protect against ASF, using bovine herpesvirus 4 (BoHV-4) as the base. This technique capitalizes on the latest advancements in ASF vaccine studies and swine immunology to craft more effective vaccines. The project is financially backed by the U.K.’s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC).

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

What Is the Regional Outlook for the Porcine Vaccine Market?

North America is the largest region in the porcine vaccine market in 2024. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9111

This Report Delivers Insight On:

1. How big is the porcine vaccine market, and how is it changing globally?

2. Who are the major companies in the porcine vaccine market, and how are they performing?

3. What are the key opportunities and risks in the porcine vaccine market right now?

4. Which products or customer segments are growing the most in the porcine vaccine market?

5. What factors are helping or slowing down the growth of the porcine vaccine market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model